Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dicker

Showing results (281-290 of 375) with videos related to

Pageof 38
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
Correction: The Retinoblastoma Tumor Suppressor Modulates DNA Repair and RadioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2020
Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate CancerJianqing Lin, Robert B Den, Jacob Greenspan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2014
The retinoblastoma tumor suppressor modulates DNA repair and radioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Reanalysis of cancer drugs: old drugs, new tricksGeorge F Vande Woude, Gary J Kelloff, Raymond W Ruddon, et al.
American Journal of Clinical Oncology|September 21, 2013
Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomesMark V Mishra, Eli D Scher, Jocelyn Andrel, et al.
JCO Clinical Cancer Informatics|February 4, 2025
Patient-Reported Outcomes: Comparing Functional Avoidance and Standard Thoracic Radiation Therapy in Lung CancerSpencer J Poiset, Joseph Lombardo, Edward Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2018
Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung CancerChellappagounder Thangavel, Ettickan Boopathi, Yi Liu, et al.
The Lancet. Oncology|September 21, 2007
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trialLi-Yan Khor, Kyounghwa Bae, Alan Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2026
Cross-Institutional Validation of a novel LLM-Based Cardiac Event Extraction framework from Electronic Health RecordsWenchao Cao, Isis Lloyd, Michael Dichmann, et al.
Journal of Neuro-Oncology|January 30, 2016
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomasWenyin Shi, Joshua D Palmer, Maria Werner-Wasik, et al.
Pageof 38

Showing results (281-290 of 375) with videos related to

Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
Correction: The Retinoblastoma Tumor Suppressor Modulates DNA Repair and RadioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2020
Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate CancerJianqing Lin, Robert B Den, Jacob Greenspan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2014
The retinoblastoma tumor suppressor modulates DNA repair and radioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Reanalysis of cancer drugs: old drugs, new tricksGeorge F Vande Woude, Gary J Kelloff, Raymond W Ruddon, et al.
American Journal of Clinical Oncology|September 21, 2013
Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomesMark V Mishra, Eli D Scher, Jocelyn Andrel, et al.
JCO Clinical Cancer Informatics|February 4, 2025
Patient-Reported Outcomes: Comparing Functional Avoidance and Standard Thoracic Radiation Therapy in Lung CancerSpencer J Poiset, Joseph Lombardo, Edward Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2018
Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung CancerChellappagounder Thangavel, Ettickan Boopathi, Yi Liu, et al.
The Lancet. Oncology|September 21, 2007
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trialLi-Yan Khor, Kyounghwa Bae, Alan Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2026
Cross-Institutional Validation of a novel LLM-Based Cardiac Event Extraction framework from Electronic Health RecordsWenchao Cao, Isis Lloyd, Michael Dichmann, et al.
Journal of Neuro-Oncology|January 30, 2016
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomasWenyin Shi, Joshua D Palmer, Maria Werner-Wasik, et al.
Pageof 38